Skip to main content

EGATEN

NDC 0078-0937 · Novartis Pharmaceuticals Corporation

Generic nametriclabendazole
Dosage formTABLET
RouteORAL
Active ingredient(s)TRICLABENDAZOLE
Strength250 mg/1
Pharmacologic classAnthelmintic [EPC], Anthelmintics [CS], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2A6 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA]
Marketing categoryNDA

Packages

0078-0937-91 — 4 TABLET in 1 BLISTER PACK (0078-0937-91)

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.